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Background: Elevated blood glucose (BG) is associated with an adverse prognosis in 
acute myocardial infarction (AMI) patients. While guidelines recommend insulin therapy 
to lower markedly elevated BG in AMI patients, it is unknown whether these 
recommendations have impacted BG management over time. Methods: We studied 
39,775 AMI patients hospitalized from 2000 to 2008 in 55 US medical centers 
contributing to Health Facts, a national database with extensive data on in-hospital BG 
and insulin use. Using all available BG measures during the hospital stay, we restricted 
our analysis to patients with a mean BG ≥200mg/dl and examined temporal trends in 
insulin use with hierarchical logistic regression models. Results: Overall, 4330 patients 
(11% of the entire cohort) had mean hospitalization BG ≥ 200 mg/dL and this proportion 
decreased from 2000 to 2008 (12% to 8%, p for trend<0.001); 75% of these patients 
had diabetes. In total, 61% of AMI patients with mean BG ≥ 200 received any insulin 
and only 16% received intravenous (IV) insulin during hospitalization. Hierarchical 
multivariable models showed an increased likelihood of insulin use over time (Figure). 
However, about one in three patients continued to receive no treatment for markedly 
elevated BG. Conclusions: Despite some improvement over time, insulin treatment 
rates among hospitalized AMI patients with severe, sustained hyperglycemia remain 
low. These findings likely reflect continuing uncertainty regarding optimal BG 
management during AMI. 
 
